A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MIN / minodronate

[Related PubMed/MEDLINE]
Total Number of Papers: 9
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MIN  (>> Co-occurring Abbreviation)
Long Form:   minodronate
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison. BMD, RA, RIS
2018 Minodronate treatment improves low bone mass and reduces progressive thoracic scoliosis in a mouse model of adolescent idiopathic scoliosis. AIS, BMD, TR
2017 Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study. BAP, Ca, eGFR, ELD, H-BMD, Hcy, IBN, IP, LBMD, PTH, TRACP-5b
2017 Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D3 and alters values of parathyroid hormone, pentosidine, and bone metabolic markers. BAP, BP, PTH, RIS, TRACP
2017 The Pharmacological Profile of a Novel Highly Potent Bisphosphonate, OX14 (1-Fluoro-2-(Imidazo-[1,2-alpha]Pyridin-3-yl)-Ethyl-Bisphosphonate). FPPS, HAP, RIS, ZOL
2016 Comparison of the effects of 12months of monthly minodronate monotherapy and monthly minodronate combination therapy with vitamin K2 or eldecalcitol in patients with primary osteoporosis. BMD, ELD
2016 Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate. OP, RIS
2008 Efficacy of a nitrogen-containing bisphosphonate, minodronate, in conjunction with a p38 mitogen activated protein kinase inhibitor or doxorubicin against malignant bone tumor cells. DOX, ERK, MAPK
2006 Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells. INC